This inventor holds 36 USPTO granted patents and 31 published patent applications, plus 6 CIPO patents and 11 EPO patents, primarily in Continuous Glucose Monitoring. Top assignees: Dexcom, Inc., Ortho-Clinical Diagnostics, Inc. Active years: 2018-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018-2026
Areas of Expertise:
Title: **Innovator Profile: Andrew Attila Pal**
Introduction
Andrew Attila Pal is a notable inventor based in San Diego, California, with an impressive portfolio of 32 patents. His work primarily focuses on innovative solutions in the medical technology sector, particularly in diabetes management. Pal's contributions have the potential to significantly improve the quality of life for individuals living with diabetes.
Latest Patents
Among his latest patents, one of the prominent innovations is a system and method for distributing continuous glucose data. This patent relates to systems, devices, and methods for receiving biosensor data acquired by medical devices, specifically targeting glucose concentration values. The invention emphasizes controlling the access and distribution of glucose data through various applications on devices, such as smartphones.
Another significant patent is for a system and method designed to provide personalized guidance to diabetes patients. This innovation aims to determine the optimal timing for delivering guidance related to the management of physiological conditions, particularly diabetes. By analyzing models and patterns, this method enhances the effectiveness of glucose concentration management, ensuring timely assistance for patients.
Career Highlights
Andrew Attila Pal is currently engaged with Dexcom, Inc., a leading company in the field of continuous glucose monitoring systems. His role at Dexcom allows him to contribute to cutting-edge technologies that provide real-time glucose monitoring and support for diabetes management. His extensive experience and dedication have positioned him as an influential figure in the medical technology landscape.
Collaborations
Pal has worked alongside talented professionals, including coworkers Apurv Ullas Kamath and Peter C. Simpson. These collaborations highlight his ability to work effectively with others in the field to drive innovation and push the boundaries of what is possible in diabetes management technologies.
Conclusion
With 32 patents to his name, Andrew Attila Pal exemplifies a commitment to advancing medical technology through innovative solutions. His work at Dexcom, Inc. illustrates his dedication to improving healthcare for individuals with diabetes. As we look to the future, Pal's ongoing innovations are likely to have a lasting impact on the industry and the lives of many patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile